PT  - JOURNAL ARTICLE
AU  - Li, Min
AU  - Meares, Claude F.
AU  - Salako, Qansy
AU  - Kukis, David L.
AU  - Zhong, Gao-Ren
AU  - Miers, Laird
AU  - DeNardo, Sally J.
TI  - Prelabeling of Chimeric Monoclonal Antibody L6 with <sup>90</sup>Yttrium- and <sup>111</sup>Indium-1,4,7,10-tetraazacyclododecane-<em>N,N′,N″,N‴</em>-tetraacetic acid (DOTA) Chelates for Radioimmunodiagnosis and Therapy
DP  - 1995 Dec 01
TA  - Cancer Research
PG  - 5726s--5728s
VI  - 55
IP  - 23 Supplement
4099  - http://cancerres.aacrjournals.org/content/55/23_Supplement/5726s.short
4100  - http://cancerres.aacrjournals.org/content/55/23_Supplement/5726s.full
SO  - Cancer Res1995 Dec 01; 55
AB  - 90Y and 111In have been attached to chimeric monoclonal antibody L6 with a bifunctional chelating agent (DOTA-peptide isothiocyanate). The bifunctional chelating agent was prelabeled with either radiometal and then conjugated to the antibody. Studies in human patients showed excellent 111In single-photon emission computed tomography images of breast cancer lesions 24 h after injection. ©1995 American Association for Cancer Research.